Eisai, Biogen receives US FDA approval for Alzheimer’s drug, applies for full approval
Jan 7 (Reuters) – The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) for patients in …